The current available data highlight the crucial roles played by IFN-γ signaling, oxidative stress, mitochondrial damage, the UPR, and NF-κB signaling in influencing oligodendrocyte viability in MS. This evidence concerns the gene NFKB1 and myeloid sarcoma.